KD6001 in Combination With Anti-PD-1 Antibody in Patients With Advanced Melanoma
Clinical trial NCT05723432 · UNKNOWN
Trial details
- NCT number
- NCT05723432
- Sponsor
- Shanghai Kanda Biotechnology Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-03-22
- Primary completion
- 2024-12-31
- Enrollment
- 84
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.